It is necessary to validate each individual IMRT treatment plan before delivery. Against the proposition.

[1]  T LoSasso,et al.  Testing of dynamic multileaf collimation. , 1996, Medical physics.

[2]  D. Low.  Quality assurance of intensity-modulated radiotherapy. , 2002, Seminars in radiation oncology.

[3]  C D Mubata,et al.  A quality assurance procedure for the Varian multi-leaf collimator. , 1997, Physics in medicine and biology.

[4]  T LoSasso,et al.  Comprehensive quality assurance for the delivery of intensity modulated radiotherapy with a multileaf collimator used in the dynamic mode. , 2001, Medical physics.

[5]  C. Ling,et al.  Physical and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy. , 1998, Medical physics.

[6]  Lei Dong,et al.  Intrafraction prostate motion during IMRT for prostate cancer. , 2001, International journal of radiation oncology, biology, physics.

[7]  G T Chen,et al.  A monitor unit verification calculation in intensity modulated radiotherapy as a dosimetry quality assurance. , 2000, Medical physics.

[8]  J. Deasy,et al.  A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. , 2001, International journal of radiation oncology, biology, physics.

[9]  Michael J. Zelefsky,et al.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.

[10]  Gary A. Ezzell,et al.  The overshoot phenomenon in step‐and‐shoot IMRT delivery , 2001, Journal of applied clinical medical physics.

[11]  D. Low,et al.  Quality assurance of serial tomotherapy for head and neck patient treatments. , 1998, International journal of radiation oncology, biology, physics.